This inventor holds 1 USPTO granted patent. Top assignee: Teagasc, the Agriculture and Food Development Authority. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Edward Lavelle and Vaccine Adjuvant Innovation.
Introduction
Edward Lavelle is an inventor based in Dublin, Ireland. His work includes the patent “Vaccine Adjuvants,” and he is associated with Teagasc, the Agriculture and Food Development Authority.
Latest Patents
Lavelle is credited with 1 patent, titled “Vaccine Adjuvants.” The title indicates a focus on adjuvants, which are components used in vaccine formulations to support or enhance immune responses.
Career Highlights
Lavelle’s listed patent connects his inventive work with vaccine research. His association with Teagasc places this work alongside the organization’s broader research and development activities.
Collaborations
His listed coworkers include Sarah Doyle and Ciaran Harte. The available information identifies them as colleagues but does not specify their roles in the patent.
Conclusion
Edward Lavelle’s recorded invention, “Vaccine Adjuvants,” reflects his contribution to patent activity in vaccine-related research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile